エピソード

  • Significance of a Multidisciplinary Approach for NMBAs with J. Ross Renew, MD, FASA, FASE and Richard Pence, CRNA, MHA

    Significance of a Multidisciplinary Approach for NMBAs with J. Ross Renew, MD, FASA, FASE and Richard Pence, CRNA, MHA
    2021/06/01

    In this podcast, expert clinicians will discuss the importance of a multidisciplinary team approach when managing patients receiving neuromuscular blockade therapy.
    続きを読む 一部表示
    11 分
  • Current and Emerging NMB Therapies with J. Ross Renew, MD, FASA, FASE and Anthony L. Kovac, MD

    Current and Emerging NMB Therapies with J. Ross Renew, MD, FASA, FASE and Anthony L. Kovac, MD
    2021/06/01

    In this podcast, expert clinicians will discuss the clinical data supporting the use of current and investigational neuromuscular blockade agents.
    続きを読む 一部表示
    17 分
  • Benefits and Drawbacks of Conventional Reversal Agents with J. Ross Renew, MD, FASA, FASE, and Richard Pence, CRNA, MHA

    Benefits and Drawbacks of Conventional Reversal Agents with J. Ross Renew, MD, FASA, FASE, and Richard Pence, CRNA, MHA
    2021/06/01

    In this podcast, expert clinicians will discuss the benefits and limitations of conventional reversal agents.
    続きを読む 一部表示
    14 分
  • Best Practices for Monitoring Neuromuscular Blockade with J. Ross Renew, MD, FASA, FASE, and Anthony L. Kovac, MD

    Best Practices for Monitoring Neuromuscular Blockade with J. Ross Renew, MD, FASA, FASE, and Anthony L. Kovac, MD
    2021/06/01

    In this podcast, expert clinicians will discuss the best practices for monitoring patients receiving neuromuscular blockade agents.
    続きを読む 一部表示
    15 分